Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.
about
Current and Future Clinical Applications of Zinc Transporter-8 in Type 1 Diabetes MellitusType 1 diabetes mellitus.Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies.Prevalence of Positive Diabetes-Associated Autoantibodies among Type 2 Diabetes and Related Metabolic and Inflammatory Differences in a Sample of the Bulgarian PopulationPrediction and pathogenesis in type 1 diabetes.The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8.Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome.Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age.Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-RequirementThe prevalence and predictive value of the SLC30A8 R325W polymorphism and zinc transporter 8 autoantibodies in the development of GDM and postpartum type 1 diabetes.Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodiesChanges in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.Islet autoantigens: structure, function, localization, and regulation.Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLA-DQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis studyType 1 Diabetes at-risk children highly recognize Mycobacterium avium subspecies paratuberculosis epitopes homologous to human Znt8 and Proinsulin.ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and AdolescentsAlloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes.The Level of Autoantibodies Targeting Eukaryote Translation Elongation Factor 1 α1 and Ubiquitin-Conjugating Enzyme 2L3 in Nondiabetic Young Adults.Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's diseaseTracing the Pathogenesis of Type 1 Diabetes: A Report on the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD)Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection.Advances in the cellular immunological pathogenesis of type 1 diabetesCurrent understanding of ZIP and ZnT zinc transporters in human health and diseases.Molecular mechanisms in autoimmune type 1 diabetes: a critical review.Latent autoimmune diabetes of the adult: current knowledge and uncertaintyShould There be Concern About Autoimmune Diabetes in Adults? Current Evidence and Controversies.Mapping of conformational autoantibody epitopes in ZNT8.Proinsulin and MAP3865c homologous epitopes are a target of antibody response in new-onset type 1 diabetes children from continental Italy.Sardinian Type 1 diabetes patients, Transthyretin and Mycobacterium avium subspecies paratuberculosis infection.Latent autoimmune diabetes in adults in Asians: similarities and differences between East and West.Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.Intrafamilial spread of enterovirus infections at the clinical onset of type 1 diabetes.Comparison of autoantibody-positive and autoantibody-negative pediatric participants enrolled in the T1D Exchange clinic registry.Zinc as a Gatekeeper of Immune Function.Adult-onset autoimmune diabetes: current knowledge and implications for management.Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes.Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes.Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes.
P2860
Q26796516-66F3C74E-38E7-4E29-AADE-D197C18CB5CDQ30235021-0C87C8DC-17B8-4027-A5DE-A2739B55E070Q33700991-9D45EC17-29E5-44BC-B16A-D9FBEB614A72Q33717570-7F584420-CE63-42A6-835C-F70925234BE5Q33818896-FC76C3C4-5BD4-4260-8823-B724178596E8Q34234608-750E337B-C447-496C-B329-7A2970B85BD8Q34936409-E308EBF7-321C-4143-B86C-65F5C668BA78Q35046614-142453D6-D238-44BC-A94D-26C8773D8AEDQ35123421-D7FA0939-4305-4766-A876-CEEE1D632922Q35740110-EB15FA18-DD46-42D7-85BD-F7FA4A3CD66CQ35966196-0234A335-59DF-42C7-B9C6-EAEBA2CB7503Q35976503-5F151C4E-127B-45EB-9032-2606421F99CFQ36092708-0FE8423C-0F6F-4AA4-888E-F22D3BB53C8AQ36119378-6D843EBB-2691-411E-8CB5-4A40C1548BE2Q36234353-80D4D2B8-8C54-4F8D-AB68-31D919E67572Q36249785-7E4FC84F-3C85-446A-BD9D-DB6434B731CFQ36628149-4F899B7B-C63A-4FF0-BA53-1F3D1EC6343FQ36681606-4B65EE0A-689A-47AD-98FD-759D70B8EB1FQ36796037-33DDC143-CE9A-457F-A4EF-12628011B127Q36858479-9E69D083-C64B-4332-97E8-14D81DBFDF6FQ36990055-E0738F8B-6D14-4C2B-A418-F3536013959EQ37035528-596EA3DE-31DD-4521-B81D-058E515456FBQ38030464-82EB5F81-DEE0-4CD8-A9E3-CE5DBA77AE1BQ38195946-00EEA671-A97C-4ECD-9D77-AED061EECEEAQ38202894-FE9020C6-116B-448D-9C7D-0B7E779A9497Q38206114-FAB972B6-E3B9-46AB-A414-BB6CA644DBBFQ38324198-D7129436-E487-4786-94D6-BAD2FC6B751AQ38908327-7821CD37-F3F2-4FCA-959D-101D12326834Q41063113-4B9B2C49-F06C-49AF-ACA2-BB50D9F335C0Q41346367-5065F9C2-6DD1-492C-8A06-DD3253398901Q42235404-23FD8772-0139-468F-981A-A8CCE5C878B8Q43819794-E370AAEA-055D-444D-B993-E38DD70B87EEQ44044590-35FEB5A9-E1EE-4771-9A99-3B624D24F60AQ44828250-BCFC601C-E274-4CC8-AD4A-9438FDD9606DQ46075434-420A46CD-BC02-4DC0-9730-E4BBA65D6875Q47256027-96F89199-919A-4DEB-BF31-515FBF03AC33Q47694295-96C4B52E-58CB-4C9F-A0C2-4E8C61760EC5Q48256704-5637527B-0FD4-4AE8-91C9-73093749CC5CQ50021277-4DCF450A-1BE2-4F8F-B3B6-080DB0C9EB8CQ50556599-DEFED322-156E-407D-9182-6D2AF197C374
P2860
Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Zinc transporter 8 antibodies ...... Autoimmune Diabetes (NIRAD) 4.
@ast
Zinc transporter 8 antibodies ...... Autoimmune Diabetes (NIRAD) 4.
@en
Zinc transporter 8 antibodies ...... Requiring Autoimmune Diabetes
@nl
type
label
Zinc transporter 8 antibodies ...... Autoimmune Diabetes (NIRAD) 4.
@ast
Zinc transporter 8 antibodies ...... Autoimmune Diabetes (NIRAD) 4.
@en
Zinc transporter 8 antibodies ...... Requiring Autoimmune Diabetes
@nl
prefLabel
Zinc transporter 8 antibodies ...... Autoimmune Diabetes (NIRAD) 4.
@ast
Zinc transporter 8 antibodies ...... Autoimmune Diabetes (NIRAD) 4.
@en
Zinc transporter 8 antibodies ...... Requiring Autoimmune Diabetes
@nl
P2093
P2860
P50
P356
P1433
P1476
Zinc transporter 8 antibodies ...... Autoimmune Diabetes (NIRAD) 4.
@en
P2093
Antonio Petrone
Claudio Tiberti
Emanuele Bosi
Marco Capizzi
Marialuisa Spoletini
Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study Group
Sara Bonicchio
Sergio di Pietro
P2860
P304
P356
10.2337/DC08-2305
P407
P577
2009-10-06T00:00:00Z